Review
Copyright ©The Author(s) 2020.
World J Gastroenterol. Sep 21, 2020; 26(35): 5223-5247
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5223
Table 2 Potential therapeutic approaches to impair stress granule function in cancer cells
StrategiesTargetModelsKnown impact on SGsAnticancer effect on CRCClinical trials for CRC (ID)
Targeting proteins involved in SG assembly
EGCGG3BP1Lung cancer[146]Reduction of SG assemblyYes[181]NCT02891538; NCT02321969; NCT01239095
ResveratrolG3BP1CRC[145]UnknownYes[145]NCT00433576; NCT00920803
GAP161 peptideG3BP1CRC[43]UnknownYes[43]None
RK-33DDX3CRC[182]UnknownYes[182]None
Targeting G4DNA/RNA structures
EMICORONG4DNACRC[147]UnknownYes[147]None
chANGangiogeninCRC[148]UnknownYes[148]None
(mAb), 26-2FangiogeninCRC[149]UnknownYes[149]None
Targeting AMPK/mTORC1 axis
Compound CAMPKYeast[151] CRC[152]Impairs SG assembly in yeast[151]Yes[152]None
RapamycinmTORC1CRC[183]UnknownYes[183]NCT00409994; NCT03439462
EverolimusmTORC1Breast[16]SG inhibitionYes[184]NCT01154335; NCT00419159; NCT01387880
TemsirolimusmTORC1CRC[185]UnknownYes[185]NCT00593060; NCT00827684; NCT01183663
Targeting HDACS/SIRTs
OSS_128167SIRT6Pancreas cancer[161]UnknownUnknownNo
A-452HDAC6CRC[158]UnknownYes[158]None
C1AHDAC6CRC[157]UnknownYes[157]None
ACY-1215HDAC6CRC[108]UnknownYes[108]None
MPT0G612HDAC6CRC[159]UnknownYes[159]None
Targeting SGs-associated RNA-binding proteins controlling cancer-related factors
MS-444HuRCRC[166]UnknownYes[166]None
DHTSHuRCRC[186]UnknownYes[186]None
ResveratrolRBFOX2CRC[101]UnknownYes[101]NCT00433576; NCT00920803
Targeting microtubules
PaclitaxelMicrotubulesGreen monkey kidney fibroblasts (CV-1 cells)[153]Promotes SG formationYes[187]NCT00598247; NCT00024401; NCT00667641
VinblastineMicrotubulesGreen monkey kidney fibroblasts (CV-1 cells)[153]Prevents SG assemblyYes[188]None